Literature DB >> 25972957

Pure cortical ependymoma: A rare entity.

Sanjay Bijwe1, Sameer Ansari1, Vinod Jadhav1, Deepak Palande2.   

Abstract

Ependymomas are mostly infratentorial, intraventricular tumor, accounting for 2-9% of all central nervous system tumors. Supratentorial pure cortical ependymoma are extremely rare tumor with definite ependymal morphology and uncertain histogenesis. They are mostly low grade tumor and are cured with resection, rendering them favorable prognosis. Our case is of 14-year-old female presenting with headache and convulsion of short duration. She underwent gross total excision of the tumor without radiation therapy and her follow-up is uneventful.

Entities:  

Keywords:  Cortical; ependymoma; extraventricular; supratentorial

Year:  2015        PMID: 25972957      PMCID: PMC4421963          DOI: 10.4103/1793-5482.152111

Source DB:  PubMed          Journal:  Asian J Neurosurg


Introduction

Supratentorial cortical ependymomas (CE) are unique tumor with very few cases reported so far in the literature. They occur in the superficial cortical ribbon and have no connection with the ventricular lining.[1]. These tumor have relatively benign course and shows close relationship with the recently described entity - angiocentricglioma (AG).[2]

Case Report

A 14-year-old female came with complaint of headache, vomiting and seizure since 1-month. Her systemic examination was normal. Routine laboratory examinations were normal. Computed tomography (CT) showed a large, well-defined, extra axial right frontal mass measuring 4 cm × 3 cm × 2.6 cm associated with perifocal edema [Figure 1]. Magnetic resonance imaging (MRI) revealed 4 cm × 3 cm × 2.6 cm, right frontal mass showing contrast enhancement [Figure 2]. Radiologically the differential diagnoses given were? Meningioma and? Oligodendroglioma. Cerebrospinal fluid (CSF) examination did not reveal any atypical cells. Surgical resection of the mass was planned, and the patient underwent total resection of the tumor, which was located in the parenchyma with no dural attachment. The tumor was clearly demarcated and dissected subpially from the surrounding brain parenchyma. The surgical findings suggested no relationship with the lateral ventricular system. Intraoperative squash cytology reveal [Figure 3] cellular smear showing tumor cells arranged in papillary pattern. The individual cells are round to oval nuclei with focally prominent nucleoli and moderate amount of eosinophilic cytoplasm. At places rosette like structures were also seen favoring the diagnosis of ependymoma. Histolopathological examination of the tumor demonstrated diffuse sheet of ependymal cells with focal area showing perivascular pseudorosettes and true rosettes [Figures 4 and 5]. Immunohistochemistry reveal diffuse positive reactivity for glial fibrillary acidic protein [Figure 6] and dot like positivity for epithelial membrane antigen (EMA) [Figure 7]. The Ki-67 index was 5% [Figure 8]. These findings confirmed ependymoma, World Health Organization (WHO) Grade II. The patient's postoperative course was uneventful. He reported no complaints at his 6-month follow-up, and CT and MRI revealed no recurrence.
Figure 1

Computed tomography scan showing well defined, extra axial right frontal mass measuring 4 cm × 3 cm × 2.6 cm

Figure 2

Magnetic resonance imaging showing revealed 4 cm × 3 cm × 2.6 cm right frontal mass showing contrast enhancement

Figure 3

Intra-operative squash cytology shows round to oval tumor cells in papillary pattern (H and E, ×200)

Figure 4

Microphotograph showing diffuse sheet of ependymal cells with focal area showing perivascular pseudorosette and true rosettes (H and E, ×100)

Figure 5

Microphotograph showing perivascular pseudorosette and true rosettes (H and E, ×200)

Figure 6

Immunohistochemistry showing diffuse positive reactivity for glial fibrillary acidic protein (H and E, ×200)

Figure 7

Immunohistochemistry showing dot like positivity for epithelial membrane anti-gen (H and E, ×200)

Figure 8

Immunohistochemistry showing low Ki-67 index (5%) (H and E, ×200)

Computed tomography scan showing well defined, extra axial right frontal mass measuring 4 cm × 3 cm × 2.6 cm Magnetic resonance imaging showing revealed 4 cm × 3 cm × 2.6 cm right frontal mass showing contrast enhancement Intra-operative squash cytology shows round to oval tumor cells in papillary pattern (H and E, ×200) Microphotograph showing diffuse sheet of ependymal cells with focal area showing perivascular pseudorosette and true rosettes (H and E, ×100) Microphotograph showing perivascular pseudorosette and true rosettes (H and E, ×200) Immunohistochemistry showing diffuse positive reactivity for glial fibrillary acidic protein (H and E, ×200) Immunohistochemistry showing dot like positivity for epithelial membrane anti-gen (H and E, ×200) Immunohistochemistry showing low Ki-67 index (5%) (H and E, ×200)

Discussion

Ependymomas are central nervous system (CNS) tumor arising from ependymal cells lying on the inner surface of brain ventricle and along the central spinal cord.[3] They are commonly seen in the cervico thoracic segment of the spinal central canal and fourth ventricle.[34] Supratentorial cortical ependymoma is a rare entity where the tumor is seen in cortical region without any connection to the ventricular lining.[2]. The current WHO classification of CNS tumor divide ependymoma into low grade (Grade II) and high grade (Grade III) or anaplastic ependymoma, reserving Grade I for myxopapillary ependymoma.[5] The mean age of presentation is 27 ± 19 years.[3] They frequently, but not always present with seizures, but despite their high association with epilepsy they are hardly seen in temporal lobe.[6] Our patient also presented with seizure although had a mass in frontal lobe. The pathogenesis of ependymoma remains uncertain. Some suggest that they originate from cell type other than terminally differentiated ependyma since they arise at sites where ependymal cells are absent.[6] Hegyi et al. in their reported case of ectopic retinal ependymoma proposed their origin from Muller cells, concluding that glial cells with progenitor properties are the cell of origin for these tumor rather than terminally differentiated ependyma.[7] Progenitor cell hypothesis could be suggested to explain the origin of CE as their occurrence in teratomas seem to support this view.[8910] Roentgenographically, it shows a well-defined solid to cystic mass located in peripheral cortical rim with minimal associated vasogenic edema.[3] On squash cytology it reveal cellular smear comprised of tumor cells in papillary pattern against fibrillary background with focal area showing perivascular pseudorosettes. The cells show round nucleus with stippled chromatin and 1–2 small nucleoli.[11] Histopathology shows true ependymal rosettes and perivascular peudorosettes which are the characteristic features defining these tumors. Less typical morphological features that can be seen include tanycytic, epithelioid and clear cell features.[3]. Rarely it can show additional spindle cell component and schwannian like nodules features that are typical of AG as described by Lehman.[12]. Our case did not show the above described features ruling out the possibility of AG. AG are seizure associated tumor characterized by an angiocentric pattern of growth, monomorphous bipolar cells and features of ependymal differentiation.[13] The close differential that can also be considered for this tumor is astroblastoma, which also reveals rosettes which have shorter and stouter cytopasmic processes when compared to rosettes of ependymoma.[14] Immunohistochemistry plays a pivotal role in differentiating these two entities as EMA shows dot like positivity in ependymomas, which is characteristic for this tumor.[2] Anaplastic Grade III ependymomas are characterized by increased cellularity, marked mitotic activity, microvascular proliferation and pseudopalisading necrosis. It is important to identify anaplastic ependymoma as it shows increased chances of recurrences and requires radiation therapy along with survival resection.[1] Metastatic seeding along the CSF pathway is frequently seen and is widespread in anaplastic form.[1] Hence, preoperative CSF examination for ruling out metastatic seeding along with postoperative MRI to evaluate the extent of excision is mandatory. Surgical excision is the main modality of treatment in Grade II ependymomas, whereas anaplastic ependymomas require surgical resection along with radiation therapy.[121516171819] The 5 year survival rate as described by Metellus et al. is 57.1% ±8.7%.[20] Therefore CE appear to have a relatively favorable prognosis as compared to other ependymomas. However, it is unclear if their indolent behavior depends on an earlier presentation due to cortical involvement, their accessibility in addition to resectability or their intrinsic pathobiology.[21] Gender, histopathology type, location of tumor, extent of surgery, patient age at diagnosis plays an important role in the prognosis of these tumor.[223]
  19 in total

1.  Ependymoma: a follow-up study of 101 cases.

Authors:  S J Mork; A C Loken
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  Analysis of squash smear cytology of ependymomas.

Authors:  P Lakshmi Manasa; Megha S Uppin; C Sundaram
Journal:  Acta Cytol       Date:  2012-02-17       Impact factor: 2.319

3.  Cortical ependymoma: an unusual epileptogenic lesion.

Authors:  Jamie J Van Gompel; Kelly K Koeller; Fredric B Meyer; W Richard Marsh; Peter C Burger; Federico Roncaroli; Gregory A Worrell; Caterina Giannini
Journal:  J Neurosurg       Date:  2011-01-14       Impact factor: 5.115

4.  Primary glial tumor of the retina with features of myxopapillary ependymoma.

Authors:  Laszlo Hegyi; David Peston; Maria Theodorou; Jill Moss; Jane Olver; Federico Roncaroli
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

5.  Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival.

Authors:  M Mikami; Y Komuro; N Sakaiya; C Tei; T Kurahashi; S Komiyama; T Hirose
Journal:  Gynecol Oncol       Date:  2001-10       Impact factor: 5.482

6.  Supratentorial cortical ependymoma: report of three cases.

Authors:  Federico Roncaroli; Alessandro Consales; Antonio Fioravanti; Giovanna Cenacchi
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

Review 7.  Ependymoma of the ovary. A case report with immunohistochemical, ultrastructural, and DNA cytometric findings, as well as histogenetic considerations.

Authors:  C Guerrieri; I Jarlsfelt
Journal:  Am J Surg Pathol       Date:  1993-06       Impact factor: 6.394

8.  Cortical ependymoma or monomorphous angiocentric glioma?

Authors:  Dennis J Lum; William Halliday; Michael Watson; Andrew Smith; Andrew Law
Journal:  Neuropathology       Date:  2007-11-13       Impact factor: 1.906

9.  Both location and age predict survival in ependymoma: a SEER study.

Authors:  Courtney S McGuire; Kristin L Sainani; Paul Graham Fisher
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  2 in total

1.  The Survival and Prognostic Factors of Supratentorial Cortical Ependymomas: A Retrospective Cohort Study and Literature-Based Analysis.

Authors:  Qiguang Wang; Jian Cheng; Jiuhong Li; Si Zhang; Wenke Liu; Yan Ju; Xuhui Hui
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 6.244

Review 2.  Supratentorial cortical ependymoma: A systematic literature review and case illustration.

Authors:  Joshua A Cuoco; Andrew C Strohman; Brittany M Stopa; Michael S Stump; John J Entwistle; Mark R Witcher; Adeolu L Olasunkanmi
Journal:  Rare Tumors       Date:  2022-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.